Cargando…
Probing of Exosites Leads to Novel Inhibitor Scaffolds of HCV NS3/4A Proteinase
BACKGROUND: Hepatitis C is a treatment-resistant disease affecting millions of people worldwide. The hepatitis C virus (HCV) genome is a single-stranded RNA molecule. After infection of the host cell, viral RNA is translated into a polyprotein that is cleaved by host and viral proteinases into funct...
Autores principales: | Shiryaev, Sergey A., Cheltsov, Anton V., Strongin, Alex Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388044/ https://www.ncbi.nlm.nih.gov/pubmed/22768327 http://dx.doi.org/10.1371/journal.pone.0040029 |
Ejemplares similares
-
New Details of HCV NS3/4A Proteinase Functionality Revealed by a High-Throughput Cleavage Assay
por: Shiryaev, Sergey A., et al.
Publicado: (2012) -
Probing BoNT/A Protease Exosites: Implications for
Inhibitor Design and Light Chain Longevity
por: Xue, Song, et al.
Publicado: (2014) -
Production, crystallization and preliminary crystallographic analysis of an exosite-containing fragment of human von Willebrand factor-cleaving proteinase ADAMTS13
por: Akiyama, Masashi, et al.
Publicado: (2009) -
Antibody-based exosite inhibitors of ADAMTS-5 (aggrecanase-2)
por: Santamaria, Salvatore, et al.
Publicado: (2015) -
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
por: Janardhan, Sujit V, et al.
Publicado: (2015)